Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease: a Multicentre,Randomised, Double-blind, Placebo-controlled, Clinical Trial (MODIFI-IBD Trial)

NCT07582458 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT07582458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07582458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease: a Multicentre,Randomised, Double-blind, Placebo-controlled, Clinical Trial (MODIFI-IBD Trial)
Lead sponsor
Radboud University Medical Center
Phase
Phase 2/3
Overall status
Recruiting
Start date
August 3, 2026
Completion date
June 30, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue, inflammatory bowel disease (crohn's disease and ulcerative colitis)